Matthew Levitas
Biographic Data
| ID | 4423787 |
|---|---|
| NAME | Matthew Levitas |
| GIVEN NAMES | Matthew |
| FAMILY NAME | Levitas |
| SIGNATURE | LEVITAS M |
| AFFILIATIONS | Forensic Fluids Laboratories |
| ORCID | 0009-0002-0976-6646 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Mistaken Identity
BACKGROUND: Bromazolam (BRZ) is a novel psychoactive substance benzodiazepine drug that has recently emerged within the illicit drug supply in the United States. BRZ is not FDA-approved and is distributed in drug mixtures or as counterfeit "Xanax". We explored the BRZ prevalence from oral fluid samples submitted to our lab for testing. METHODS: BRZ-positive sample results were examined between August 2024 and November 2025. Illicit drug and other…
Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 U.S. States
The standard protocol in addiction treatment/pain management is to conduct immunoassay screens for major drugs subject to misuse, followed by confirmatory testing of positive results. However, this may miss unscreened or rarely screened drugs that could pose risks, especially to polydrug users. We sought to determine the prevalences of unscreened/rarely screened drugs in a sample of individuals misusing drugs in 7 U.S. states, and to compare the …
No prominent works on this page.
Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 U.S. States
The standard protocol in addiction treatment/pain management is to conduct immunoassay screens for major drugs subject to misuse, followed by confirmatory testing of positive results. However, this may miss unscreened or rarely screened drugs that could pose risks, especially to polydrug users. We sought to determine the prevalences of unscreened/rarely screened drugs in a sample of individuals misusing drugs in 7 U.S. states, and to compare the …
Mistaken Identity
BACKGROUND: Bromazolam (BRZ) is a novel psychoactive substance benzodiazepine drug that has recently emerged within the illicit drug supply in the United States. BRZ is not FDA-approved and is distributed in drug mixtures or as counterfeit "Xanax". We explored the BRZ prevalence from oral fluid samples submitted to our lab for testing. METHODS: BRZ-positive sample results were examined between August 2024 and November 2025. Illicit drug and other…
Drug (2 works) · Forensic Toxicology and Drug Analysis (2 works) · Opioid Use Disorder Treatment (2 works) · Benzodiazepine (1 work) · Controlled substance (1 work) · Hydroxyzine (1 work) · Illicit drug (1 work) · Immunoassay (1 work) · Immunology (1 work) · Internal Medicine (1 work)